I am not aware of another device such as yours, and… it has excellent potential. Clinically, it would be incredibly impactful; the issue of sexual function preservation is paramount for many patients undergoing prostate cancer treatment.

I have been working in Spine Deformity for 38 years. Jeffrey Owen, PhD, has been working with me for much of that time. He is a visionary, an innovator, and a “Doer”. I believe that his vision of AI-IOM, coupled with perfusion monitoring, is the next advance in this space. It has the potential to drive down monitoring costs while making the service available to more patients.

I do believe that the NVRD approach has enormous potential to reduce (postoperative functional) complications and thereby address this quality of life compromise.

Decreasing Medicare reimbursement rates make automated IOM more attractive. If your device is reliable and improves surgical outcomes, I will buy two right now.

IOM is very important to Risk Management and protecting the hospital and patient. It is difficult to find reliable, well-trained monitoring techs and monitoring companies.